Hologic appoints Wayde McMillan to Board of Directors

HOLOGIC INC

Wayde McMillan, current CFO of Solventum, appointed to Hologic's Board effective April 4, 2025.
Also appointed to the Audit and Finance Committee.
Board size increased from eight to nine directors.
McMillan previously held CFO roles at Insulet and Medtronic's Minimally Invasive Therapies Group.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Wayde McMillan

Director

HOLOGIC INC

Effective: 2025-04-04
Filed: April 4, 2025, 7:59 PM ET

increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.

Appointed

Wayde McMillan

director

HOLOGIC INC

Effective: 2025-04-04
Filed: April 4, 2025, 7:59 PM ET

appointed Wayde McMillan as a director of the Company, effective April 4, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wayde McMillan was appointed as Director at HOLOGIC INC.

Action: appointed
Role: Director

Exact text from the filing

increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Wayde McMillan was appointed as director at HOLOGIC INC.

Action: appointed
Role: director

Exact text from the filing

appointed Wayde McMillan as a director of the Company, effective April 4, 2025.

View on SEC.gov

Source: SEC EDGAR

accession 0001140361-25-012333

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.